Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin Exposure.
about
Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection Model.Differential Activity of the Combination of Vancomycin and Amikacin on Planktonic vs. Biofilm-Growing Staphylococcus aureus Bacteria in a Hollow Fiber Infection Model.
P2860
Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin Exposure.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sequential Evolution of Vancom ...... rgets for Vancomycin Exposure.
@ast
Sequential Evolution of Vancom ...... rgets for Vancomycin Exposure.
@en
type
label
Sequential Evolution of Vancom ...... rgets for Vancomycin Exposure.
@ast
Sequential Evolution of Vancom ...... rgets for Vancomycin Exposure.
@en
prefLabel
Sequential Evolution of Vancom ...... rgets for Vancomycin Exposure.
@ast
Sequential Evolution of Vancom ...... rgets for Vancomycin Exposure.
@en
P2093
P2860
P356
P1476
Sequential Evolution of Vancom ...... argets for Vancomycin Exposure
@en
P2093
Brian T Tsuji
Calvin J Meaney
Daniel A Brazeau
Michael J Rybak
Nicholas B Norgard
Steven R Gill
Tanya Brown
Zackery P Bulman
P2860
P304
P356
10.1128/AAC.02657-15
P407
P577
2015-12-28T00:00:00Z